REVERSIBLE OPENING OF THE BBB BY TARGETED SUPPRESSION OF CLAUDIN 5 TO ENHANCE DRUG DELIVERY TO BRAIN TUMORS
Publication
, Journal Article
Grant, GA; Wilson, C; Campbell, M; Humphries, P; Li, S; Li, J; Johnson, A; Bigner, D; Dewhirst, M
Published in: NEURO-ONCOLOGY
November 1, 2010
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2010
Volume
12
Start / End Page
98 / 98
Location
Hollywood, FL
Publisher
OXFORD UNIV PRESS INC
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Grant, G. A., Wilson, C., Campbell, M., Humphries, P., Li, S., Li, J., … Dewhirst, M. (2010). REVERSIBLE OPENING OF THE BBB BY TARGETED SUPPRESSION OF CLAUDIN 5 TO ENHANCE DRUG DELIVERY TO BRAIN TUMORS. NEURO-ONCOLOGY, 12, 98–98.
Grant, Gerald A., Christy Wilson, Matthew Campbell, Peter Humphries, Shuqin Li, Jianjun Li, Allan Johnson, Darell Bigner, and Mark Dewhirst. “REVERSIBLE OPENING OF THE BBB BY TARGETED SUPPRESSION OF CLAUDIN 5 TO ENHANCE DRUG DELIVERY TO BRAIN TUMORS.” NEURO-ONCOLOGY 12 (November 1, 2010): 98–98.
Grant GA, Wilson C, Campbell M, Humphries P, Li S, Li J, et al. REVERSIBLE OPENING OF THE BBB BY TARGETED SUPPRESSION OF CLAUDIN 5 TO ENHANCE DRUG DELIVERY TO BRAIN TUMORS. NEURO-ONCOLOGY. 2010 Nov 1;12:98–98.
Grant, Gerald A., et al. “REVERSIBLE OPENING OF THE BBB BY TARGETED SUPPRESSION OF CLAUDIN 5 TO ENHANCE DRUG DELIVERY TO BRAIN TUMORS.” NEURO-ONCOLOGY, vol. 12, OXFORD UNIV PRESS INC, Nov. 2010, pp. 98–98.
Grant GA, Wilson C, Campbell M, Humphries P, Li S, Li J, Johnson A, Bigner D, Dewhirst M. REVERSIBLE OPENING OF THE BBB BY TARGETED SUPPRESSION OF CLAUDIN 5 TO ENHANCE DRUG DELIVERY TO BRAIN TUMORS. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2010 Nov 1;12:98–98.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
November 1, 2010
Volume
12
Start / End Page
98 / 98
Location
Hollywood, FL
Publisher
OXFORD UNIV PRESS INC
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences